SEARCH

SEARCH BY CITATION

References

  • 1
    Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 1991; 145: 4059.
  • 2
    Seppelt U. Correlation among prostate stroma, plasma estrogen levels, and urinary estrogen excretion in patients with benign prostatic hypertrophy. J Clin Endocrinol Metab 1978; 47: 12305.
  • 3
    Trachtenberg J, Hicks LL, Walsh PC. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest 1980; 65: 10519.
  • 4
    Suzuki K, Ito K, Suzuki T, Honma S, Yamanaka H. Synergistic effects of estrogen and androgen on the prostate: effects of estrogen on androgen- and estrogen-receptors, BrdU uptake, immunohistochemical study of AR, and responses to antiandrogens. Prostate 1995; 26: 15163.
  • 5
    Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977; 37: 192933.
  • 6
    Drago JR. The induction of NB rat prostatic carcinomas. Anticancer Res 1984; 4: 2556.
  • 7
    Wolf RM, Schneider SL, Pontes JE, Englander L, Karr JP, Murphy GP, Sandberg AA. Estrogen and progestin receptors in human prostatic carcinoma. Cancer 1985; 55: 247781.
  • 8
    1 ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996; 392: 4953.
  • 9
    Kuiper GG, Enmark E, Pelto HM, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 592530.
  • 10
    Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001; 98: 63305.
  • 11
    Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Strieker PD, Grygiel JJ, Gustafsson JA, Sutherland RL. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 2001; 61: 53315.
  • 12
    Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 2001; 159: 7992.
  • 13
    Woo TH, Patel BK, Cinco M, Smythe LD, Symonds ML, Norris MA, Dohnt MF. Real-time homogeneous assay of rapid cycle polymerase chain reaction product for identification of Leptonema illini. Anal Biochem 1998; 259: 1127.
  • 14
    Santti R, Newbold RR, Makela S, Pylkkanen L, McLachlan JA. Developmental estrogenization and prostatic neoplasia. Prostate 1994; 24: 6778.
  • 15
    von Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, Dhar MD, Ganjam VK, Parmigiani S, Welshons WV. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 1997; 94: 205661.
  • 16
    Latil A, Bieche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, Vidaud M. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res 2001; 61: 191926.
  • 17
    Jarred RA, Cancilla B, Prins GS, Thayer KA, Cunha GR, Risbridger GP. Evidence that estrogens directly alter androgen-regulated prostate development. Endocrinology 2000; 141: 34717.
  • 18
    van Weerden WM, Moerings EP, van Kreuningen A, de Jong FH, van Steenbrugge GJ, Schroder FH. Ki-67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models. Cell Prolif 1993; 26: 6775.
  • 19
    Bianco JJ, Handelsman DJ, Pedersen JS, Risbridger GP. Direct response of the murine prostate gland and seminal vesicles to estradiol. Endocrinology 2002; 143: 492233.
  • 20
    Shirai T, Imaida K, Masui T, Iwasaki S, Mori T, Kato T, Ito N. Effects of testosterone, dihydrotestosterone and estrogen on 3,2′-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis. Int J Cancer 1994; 57: 2248.
  • 21
    Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst 1998; 90: 163747.
  • 22
    Shirai T, Tamano S, Kato T, Iwasaki S, Takahashi S, Ito N. Induction of invasive carcinomas in the accessory sex organs other than the ventral prostate of rats given 3,2′-dimethyl-4-aminobiphenyl and testosterone propionate. Cancer Res 1991; 51: 12649.
  • 23
    Pollard M, Luckert PH. Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: a model system. Prostate 1987; 11: 21927.
  • 24
    Shirai T, Takahashi S, Cui L, Futakuchi M, Kato K, Tamano S, Imaida K. Experimental prostate carcinogenesis-rodent models. Mutat Res 2000; 462: 21926.
  • 25
    Donnelly BJ, Lakey WH, McBlain WA. Estrogen receptor in human benign prostatic hyperplasia. J Urol 1983; 130: 1837.
  • 26
    Mobbs BG, Johnson IE, Liu Y. Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays. Prostate 1990; 16: 23544.
  • 27
    Pelletier G, El Alfy M. Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. J Clin Endocrinol Metab 2000; 85: 483540.
  • 28
    Nomura Y, Nagaya T, Tsukaguchi H, Takamatsu J, Seo H. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation. Endocrinology 1996; 137: 40826.
  • 29
    Asano K, Maruyama S, Usui T, Fujimoto N. Regulation of estrogen receptor alpha and beta expression by testosterone in the rat prostate gland. Endocr J 2003; 50: 2817.
  • 30
    Clements JA, Matheson BA, Wines DR, Brady JM, MacDonald RJ, Funder JW. Androgen dependence of specific kallikrein gene family members expressed in rat prostate. J Biol Chem 1988; 263: 161327.
  • 31
    Onozawa M, Fukuda K, Watanabe M, Ohtani M, Akaza H, Sugimura T, Wakabayashi K. Detection and cloning of a protein recognized by anti-human prostate-specific antigen (PSA) antibody in the rat ventral prostate. Jpn J Cancer Res 2001; 92: 8638.
  • 32
    Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol 2003; 21: 38391.
  • 33
    Devos A, de Clercq N, Vercaeren I, Heyns W, Rombauts W, Peeters B. Structure of rat genes encoding androgen-regulated cystatin-related proteins (CRPs): a new member of the cystatin superfamily. Gene 1993; 125: 15967.
  • 34
    Vercaeren I, Vanaken H, Devos A, Peeters B, Verhoeven G, Heyns W. Androgens transcriptionally regulate the expression of cystatin-related protein and the C3 component of prostatic binding protein in rat ventral prostate and lacrimal gland. Endocrinology 1996; 137: 471320.
  • 35
    Zhang J, Thomas TZ, Kasper S, Matusik RJ. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 2000; 141: 4698710.
  • 36
    Takeda H, Nakamoto T, Kokontis J, Chodak GW, Chang C. Autoregulation of androgen receptor expression in rodent prostate: immunohistochemical and in situ hybridization analysis. Biochem Biophys Res Commun 1991; 177: 48896.
  • 37
    Leav I, Ho SM, Ofner P, Merk FB, Kwan PW, Damassa D. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 1988; 80: 104553.